Your browser doesn't support javascript.
loading
Rheumatic syndromes and occult tumor: 10-year experience in a teaching hospital. / Síndromes reumáticos y tumor oculto, experiencia de 10 años en un hospital universitario.
Castro Corredor, David; Ramírez Huaranga, Marco Aurelio; Rebollo Giménez, Ana Isabel; Arenal López, Rocío; Cuadra Díaz, José Luis.
Affiliation
  • Castro Corredor D; Servicio de Reumatología, Hospital General Universitario de Ciudad Real, Ciudad Real, España. Electronic address: d.castrocorredor@gmail.com.
  • Ramírez Huaranga MA; Servicio de Reumatología, Hospital General Universitario de Ciudad Real, Ciudad Real, España.
  • Rebollo Giménez AI; Servicio de Reumatología, Hospital General Universitario de Ciudad Real, Ciudad Real, España.
  • Arenal López R; Servicio de Reumatología, Hospital General Universitario de Ciudad Real, Ciudad Real, España.
  • Cuadra Díaz JL; Servicio de Reumatología, Hospital General Universitario de Ciudad Real, Ciudad Real, España.
Reumatol Clin (Engl Ed) ; 16(1): 42-44, 2020.
Article de En, Es | MEDLINE | ID: mdl-29456155
ABSTRACT

OBJECTIVE:

To describe the different clinical characteristics of patients admitted to the Rheumatology Department due to rheumatic manifestations as the first expression of an unknown malignant process. PATIENTS AND

METHODS:

Retrospective and descriptive observational study involving the review of the medical records of those admitted to rheumatology in the University Hospital of Ciudad Real between January 2007 and August 2017 for initial rheumatic manifestations with a suspicion at discharge of an unknown tumor.

RESULTS:

In all, 64 patients were identified from more than 500 admissions. The most common rheumatic manifestations were inflammatory low back pain, polyarthralgia, hip pain, thoracic spine pain, cervical pain, polyarthritis and polymyalgia rheumatica. Forty-four percent had low hemoglobin, 70% had elevation of acute-phase reactants, 62% had abnormal tumor markers, 76% had metastatic lesions. In 20% the primary tumor was of pulmonary origin and only 26.56% received palliative treatment; 64% died.

DISCUSSION:

It is important to consider the possibility of an underlying malignant process in the differential diagnosis since its early identification can be determinant for prognosis.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Métastases d'origine inconnue / Rhumatismes Type d'étude: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male Langue: En / Es Journal: Reumatol Clin (Engl Ed) Année: 2020 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Métastases d'origine inconnue / Rhumatismes Type d'étude: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male Langue: En / Es Journal: Reumatol Clin (Engl Ed) Année: 2020 Type de document: Article